Pain Management for Sickle Cell Disease Patients

Introduction to Pain Management

The American Academy of Pediatrics recommends that pain management in sickle cell disease (SCD) patients should be aggressive, prompt, and follow a predetermined personalized analgesic plan of care, as pain episodes are the hallmark of SCD and are often undertreated 1
Patients with SCD are often stigmatized when seeking pain relief due to lack of objective physical findings, and studies have documented disparities in pain management between racial groups, with children of color receiving less pain medication 1
Patients and their caregivers often know their disease best and should be involved in treatment decisions, and shared decision-making between patients, families, and healthcare providers is crucial 1

Rapid triage, assessment, and aggressive parenteral analgesia are essential for severe pain, and parenteral opioids (such as morphine) are indicated and should be administered by a healthcare provider 1
The American Academy of Pediatrics suggests that for severe pain, scheduled around-the-clock dosing, or patient-controlled analgesia (PCA) can be used 1
Close observation for development of other complications, particularly acute chest syndrome, is necessary, and acute chest syndrome can develop after initial presentation for pain and is characterized by new segmental infiltrate on chest radiograph, lower respiratory tract symptoms, chest pain and/or hypoxemia 1

For patients with frequent pain requiring healthcare interventions who fail to respond to standard care, consider related matched allogeneic transplantation, as recommended by the Blood Advances journal 2
Disease-modifying therapies like hydroxyurea can help prevent sickle hemoglobin polymerization and reduce frequency of acute pain episodes, although the strength of evidence for this is not provided in the article

Delays in addressing pain and undertreatment of SCD pain are common and should be avoided, as recommended by the American Academy of Pediatrics 1
Avoid unnecessary repeat screening for hemoglobinopathy in patients with established diagnosis, as recommended by the Anaesthesia journal 3
Last-minute cancellations for administrative reasons should be avoided, particularly if the patient has received blood transfusion in preparation for surgery, as recommended by the Anaesthesia journal 3